12:00 AM
 | 
Sep 24, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Matrix metalloproteinase 2 (MMP2); MMP9; MMP14

Cancer

INDICATION: Cancer

Cell and mouse studies identified an inhibitor of MMP2, MMP9, and MMP14 that could help treat cancer. Chemical synthesis and testing in an MMP binding assay of sulfonamide hydroxamate analogs identified a compound...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >